Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.
第一作者:
Dominic,Kelly
第一单位:
Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, UK.
作者:
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);女(雌)性(Female);人类(Humans);男(雄)性(Male);基质金属蛋白酶9(Matrix Metalloproteinase 9);心肌梗死(Myocardial Infarction);利钠肽, 脑(Natriuretic Peptide, Brain);肽碎片(Peptide Fragments);预后(Prognosis);前瞻性研究(Prospective Studies);金属蛋白酶1组织抑制剂(Tissue Inhibitor of Metalloproteinase-1);治疗结果(Treatment Outcome);心室功能障碍, 左(Ventricular Dysfunction, Left);心室重构(Ventricular Remodeling)
DOI
10.1093/eurheartj/ehn315
PMID
18614523
发布时间
2025-05-29
基金项目
PG/03/155/16412/BHF_/British Heart Foundation/United Kingdom
- 浏览22
European heart journal
2116-24页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



